RavenQuest BioMed Inc.
RVVQF · OTC
7/31/2019 | 4/30/2019 | 1/31/2019 | 10/31/2018 | |
|---|---|---|---|---|
| Market Cap | $47,505 | $76,272 | $77,481 | $74,815 |
| - Cash | $749 | $1,304 | $956 | $363 |
| + Debt | $14,780 | $15,444 | $14,677 | $13,259 |
| Enterprise Value | $61,536 | $90,412 | $91,201 | $87,711 |
| Revenue | $710 | $653 | $300 | -$141 |
| % Growth | 8.6% | 117.7% | 312.8% | – |
| Gross Profit | $443 | -$131 | -$165 | -$184 |
| % Margin | 62.4% | -20.1% | -55% | 130.5% |
| EBITDA | -$1,421 | -$1,955 | -$1,647 | -$20,835 |
| % Margin | -200.2% | -299.3% | -548.9% | 14,776.6% |
| Net Income | -$3,124 | -$3,205 | -$3,194 | -$22,826 |
| % Margin | -440.2% | -490.6% | -1,064.6% | 16,188.7% |
| EPS Diluted | -0.026 | -0.028 | -0.028 | -0.21 |
| % Growth | 6.1% | 1.8% | 86.5% | – |
| Operating Cash Flow | -$1,438 | -$872 | $1,525 | -$150 |
| Capital Expenditures | -$655 | -$1,504 | -$1,677 | -$3,339 |
| Free Cash Flow | -$2,093 | -$2,376 | -$152 | -$3,489 |